English  |  正體中文  |  简体中文  |  2823489  
???header.visitor??? :  30352715    ???header.onlineuser??? :  1036
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"余明隆"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 221-230 of 304  (31 Page(s) Totally)
<< < 18 19 20 21 22 23 24 25 26 27 > >>
View [10|25|50] records per page

Institution Date Title Author
高雄醫學大學 2005 感染基因型第二型之慢性C型肝炎病患以長效型干擾素合併Rivbavirin治療16及24週療程之比較:期中分析  戴嘉言;余明隆;李立柏;謝明彥;侯乃仁;黃志富;丘長富;林子堯;陳信成;謝明裕;王良彥;莊萬龍;張文宇 
高雄醫學大學 2005 Polymorphisms in the Interferon-gamma gene at position +874 in patients with chronic Hepatitis C treated with high dose Interferon-Alpha and Ribavirin  戴嘉言;莊萬龍;張文宇;陳信成;李立柏;謝明彥;侯乃仁;林子堯;謝明裕;王良彥;余明隆 
高雄醫學大學 2005 THE POLYMORPHISM OF EIF-2α GENE REGULATORY REGION 2 AND CLINICAL FEATURE OFCHRONIC HEPATITIS C AND RESPONSE TO COMBINATION THERAPY WITH HIGH DOSE INTERFERON AND RIBAVIRINTION  戴嘉言;余明隆;李立柏;謝明彥;莊萬龍;張文宇 
高雄醫學大學 2005 Tumor necrosis factor alpha promoter polymorphisms at position –308 predict hepatitis C virus response to combination therapy with high dose interferon and ribavirin  戴嘉言;余明隆;莊萬龍;李立柏;謝明彥;侯乃仁;王良彥;張文宇 
高雄醫學大學 2004 檳榔是肝硬化病人併發肝癌的危險因子  蔡榮發;鄭貞英;莊麗月;林子堯;謝明裕;陳信成;莊萬龍;王良彥;余明隆;戴嘉言 ; Tsai JF;Jeng JE;Chuang LY;Ho MS;Ko YC;Lin ZY;Hsieh MY;Chen SC;Chuang WL;Wang LY;Yu ML;Dai CY 
高雄醫學大學 2004 A prospective study on treatment of chronic hepatitis C with tailored and extended interferon-alpha regimens according to pretreatment virological factors  余明隆;戴嘉言;陳信成;李立柏;黃志富;林子堯;謝明裕;王良彥;莊萬龍;張文宇 ; Ming-Lung Yu;Chia-Yen Dai;Shinn-Cherng Chen;Li-Po Lee;Jee-Fu Huang;Zu-Yau Lin;Ming-Yuh Hsieh;Liang-Yen Wang;Wan-Long Chuang;Wen-Yu Chang 
高雄醫學大學 2004 Randomized trial of three different regimens for 24 weeks for re-treatment of chronic hepatitis C patients who failed to respond to interferon-alpha monotherapy in Taiwan.  莊萬龍;戴嘉言;陳信成;李立柏;林子堯;謝明裕;王良彥;余明隆;張文宇 ; Wan-Long Chuang;Chia-Yen Dai;Shinn-Cherng Chen;Li-Po Lee;Zu-Yau Lin;Ming-Yuh Hsieh;Liang-Yen Wang;Ming-Lung Yu;Wen-Yu Chang . 
高雄醫學大學 2004 The prevalence and clinical characteristics of coinfection of SENV-H among Taiwanese chronic hepatitis C patients with combination therapy of high-dose interferon-alfa and ribavirin.  戴嘉言;莊萬龍;張文宇;陳信成;李立柏;林子堯;侯乃仁;謝明裕;王良彥;余明隆 ; Chia-Yen Dai;Wan-Long Chuang;Wen-Yu Chang;Shinn-Cherng Chen;Li-Po Lee;Zu-Yau Lin;Nai-Jen Hou;Ming-Yuh Hsieh;Liang-Yen Wang;Ming-Lung Yu . 
高雄醫學大學 2004 Clinical significance of TT virus (TTV) infection in chronic hepatitis C patients with high dose interferon-alpha therapy in Taiwan: re-evaluated by using new set of TTV primers.  戴嘉言;余明隆;林子堯;陳信成;謝明彥;李立柏;侯乃仁;謝明裕;王良彥;蔡榮發;莊萬龍;張文宇 ; Chia-Yen Dai;Ming-Lung Yu;Zu-Yau Lin;Shinn-Cherng Chen;Ming-Yen Hsieh;Li-Po Lee;Nai-Jen Hou;Ming-Yuh Hsieh;Liang-Yen Wang;Jung-Fa Tsai;Wan-Long Chuang;Wen-Yu Chang 
高雄醫學大學 2004 南台灣慢性C型肝炎患者SEN病毒D盛行率、臨床表徵及對干擾素合併ribavirin治療療效之影響(93春)  謝明彥;戴嘉言;余明隆;陳信成;莊萬龍;張文宇 

Showing items 221-230 of 304  (31 Page(s) Totally)
<< < 18 19 20 21 22 23 24 25 26 27 > >>
View [10|25|50] records per page